Request page removalAbout Chris Mansi
Chris Mansi is an angel investor and an entrepreneur. They did their education from Stanford. Their journey in the startup ecosystem started in 2021 through HumanFirst. Chris Mansi has founded 1 company. They are currently acting as the, and as the co-founder of Viz.ai. As an angel investor, Chris Mansi has a portfolio of 3 companies, focusing primarily on sectors like HealthTech, Enterprise Applications and 2 more sectors. They invest in companies across United States. Their most notable investments include companies like Neuralight and Canopy Care.
Key Metrics
Founded
Investment Portfolio
Top sectors of Investment
Top locations of Investment
Chris Mansi's Investments
Chris Mansi has invested in 3 companies. Their most recent investment was in Neuralight (Series A Round) on May 24, 2022. Their investments are primarily in HealthTech, Enterprise Applications and 2 more sectors. Their investment portfolio companies are located in United States.Here are the details of all recent investments by Chris Mansi:
Date | Company | Round | Round Amount | Co-Investors |
|---|---|---|---|---|
May 24, 2022 | Series A | $25M | ||
Mar 17, 2022 | Series B | $13M | ||
Jun 01, 2021 | Series A | $12M |
Want to explore profiles similar to Chris Mansi?
Let us walk you through our investor database and other offerings.
Let us walk you through our investor database and other offerings.
Chris Mansi's Portfolio Exits
Chris Mansi has 1 Portfolio Exit which is HumanFirst.
Here is the detail of this portfolio exit:
Company | Description | Location | Total Funding | Founded Year | Exit Type | Exit Date |
|---|---|---|---|---|---|---|
Remote monitoring platform for healthcare professionals | San Francisco (United States) | $15M | 2017 | Acquisition | Feb 29, 2024 |
Chris Mansi's Founded Companies
Chris Mansi has founded Viz.ai.
Here is the detail of this founded company:
Company | Short Description | Total Funding | Founded Year | Current Stage | Location |
|---|---|---|---|---|---|
Developer of an AI-powered platform for care coordination and disease detection | $252M | 2016 | Series D | San Francisco |
FAQs about Chris Mansi
Recently updated other profiles
